These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1610710)

  • 1. Levels of fusidic acid in skin blister fluid and serum after repeated administration of two dosages (250 and 500 mg).
    Vaillant L; Machet L; Taburet AM; Sorensen H; Lorette G
    Br J Dermatol; 1992 Jun; 126(6):591-5. PubMed ID: 1610710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers.
    Warlich R; Korting HC; Schäfer-Korting M; Mutschler E
    Antimicrob Agents Chemother; 1990 Jan; 34(1):78-81. PubMed ID: 2327762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin tissue fluid levels of cefotiam in healthy man following oral cefotiam hexetil.
    Korting HC; Schäfer-Korting M; Kees F; Lukacs A; Grobecker H
    Eur J Clin Pharmacol; 1990; 39(1):33-6. PubMed ID: 2276386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.
    Borin MT; Hughes GS; Spillers CR; Patel RK
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1094-9. PubMed ID: 2393268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
    Vaillant L; Le Guellec C; Jehl F; Barruet R; Sorensen H; Roiron R; Autret-Leca E; Lorette G
    Ann Dermatol Venereol; 2000 Jan; 127(1):33-9. PubMed ID: 10717560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state.
    Kalager T; Digranes A; Bergan T; Rolstad T
    J Antimicrob Chemother; 1986 Jun; 17(6):795-800. PubMed ID: 3460984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoconazole concentrations in human skin blister fluid and plasma.
    Schäfer-Korting M; Korting HC; Dorn M; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):371-4. PubMed ID: 6088407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human plasma and skin blister fluid levels of griseofulvin after its repeated administration.
    Schäfer-Korting M; Korting HC; Mutschler E
    Eur J Clin Pharmacol; 1985; 29(3):351-4. PubMed ID: 4076331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefodizime penetration into skin suction blister fluid following a single intravenous dose.
    Schäfer-Korting M; Korting HC; Maass L; Klesel N; Grigoleit HG; Mutschler E
    Eur J Clin Pharmacol; 1986; 30(3):295-8. PubMed ID: 3732363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid.
    Kalager T; Digranes A; Bergan T; Solberg CO
    J Antimicrob Chemother; 1984 May; 13(5):479-85. PubMed ID: 6330020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration and bactericidal activity of fusidic acid and cloxacillin in serum and synovial fluid.
    Somekh E; Golan T; Tanay A; Poch F; Dan M
    J Antimicrob Chemother; 1999 Apr; 43(4):593-6. PubMed ID: 10350394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of tinidazole into skin blister fluid following its oral administration.
    Klimowicz A; Nowak A; Bielecka-Grzela S
    Eur J Clin Pharmacol; 1992; 43(5):523-6. PubMed ID: 1483489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.
    Schäfer-Korting M; Korting HC; Mutschler E
    Eur J Clin Pharmacol; 1985; 29(1):109-13. PubMed ID: 4054199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance.
    Bulitta JB; Okusanya OO; Forrest A; Bhavnani SM; Clark K; Still JG; Fernandes P; Ambrose PG
    Antimicrob Agents Chemother; 2013 Jan; 57(1):498-507. PubMed ID: 23147726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in blister fluid penetration after single and multiple doses of ceftriaxone.
    LeBel M; Grégoire S; Caron M; Bergeron MG
    Antimicrob Agents Chemother; 1985 Jul; 28(1):123-7. PubMed ID: 4037771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration.
    Schäfer-Korting M; Korting HC; Lukacs A; Heykants J; Behrendt H
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):211-5. PubMed ID: 2155951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of griseofulvin in blood and skin suction blister fluid of rats.
    Schäfer-Korting M
    Drug Metab Dispos; 1987; 15(3):374-6. PubMed ID: 2886314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
    Turnidge J
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S23-34. PubMed ID: 10528784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose.
    Fetterly GJ; Ong CM; Bhavnani SM; Loutit JS; Porter SB; Morello LG; Ambrose PG; Nicolau DP
    Antimicrob Agents Chemother; 2005 Jan; 49(1):148-52. PubMed ID: 15616289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.